Back to Companies
Werewolf Therapeutics, Inc.
HOWLNasdaqCIK: 0001785530
Over the 50 most recent insider filings, Werewolf Therapeutics, Inc. (HOWL) has seen activity from 5 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $7.7M sold, net sales of $7.7M. EVNIN LUKE is the most active by dollar volume, and the single largest transaction was $446.4K by GADICKE ANSBERT. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$7.7M
Purchases
$0
Sales
$7.7M
Unique Insiders
5
Recent Insider Trades
50 loaded
| Jul 8 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $44.7K |
| Jun 29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $47.1K |
| Jun 22 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $145.9K |
| Jun 16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $173.8K |
| Jun 11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $253.6K |
| Jun 10 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $28.5K |
| Jun 8 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $43.0K |
| Jun 3 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $63.6K |
| May 29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $66.2K |
| May 26 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $86.6K |
| May 20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $76.4K |
| May 12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $280.2K |
| May 12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $390.7K |
| May 7 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $64.2K |
| Apr 29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $154.5K |
| Mar 13 | HOWL Werewolf Therapeutics, Inc. | Urban Michael J. | Insider | Other | $0 |
| Jan 20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $20.9K |
| Jan 15 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $61.8K |
| Jan 12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $53.5K |
| Jan 7 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $45.9K |
| Jan 2 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $48.4K |
| Dec 29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $185.2K |
| Dec 17 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $52.0K |
| Dec 12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $88.6K |
| Dec 9 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $94.8K |
| Dec 4 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $183.3K |
| Dec 4 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $183.3K |
| Dec 4 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $117.6K |
| Dec 1 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $136.9K |
| Dec 1 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $136.9K |
| Dec 1 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $87.8K |
| Nov 25 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $179.6K |
| Nov 25 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $115.2K |
| Nov 25 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $179.6K |
| Nov 20 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $147.9K |
| Nov 20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $94.9K |
| Nov 20 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $147.9K |
| Nov 17 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $200.7K |
| Nov 17 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $200.7K |
| Nov 17 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $128.8K |
| Nov 12 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $241.3K |
| Nov 12 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $241.3K |
| Nov 12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $154.9K |
| Nov 6 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $295.8K |
| Nov 6 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $295.8K |
| Nov 6 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $189.8K |
| Nov 3 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $391.6K |
| Nov 3 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE | Insider | Sell | $251.3K |
| Nov 3 | HOWL Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $391.6K |
| Oct 29 | HOWL Werewolf Therapeutics, Inc. | GADICKE ANSBERT | Insider | Sell | $446.4K |
50 filings+